Greystone Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.29M Buy
+84,722
New +$5.35M 1.47% 32
2025
Q2
– Sell
-160,028
Closed -$9.8M – 95
2025
Q1
$9.8M Buy
+160,028
New +$9.33M 1.77% 23
2023
Q4
– Sell
-56,250
Closed -$3.26M – 109
2023
Q3
$3.26M Buy
56,250
+1,334
+2% +$81.7K 0.81% 47
2023
Q2
$3.51M Buy
+54,916
New +$3.68M 0.81% 45
2022
Q2
– Sell
-117,798
Closed -$8.6M – 72
2022
Q1
$8.6M Sell
117,798
-1,265
-1% -$84.9K 2.17% 15
2021
Q4
$7.42M Buy
119,063
+26,071
+28% +$1.53M 1.78% 33
2021
Q3
$5.5M Sell
92,992
-13,699
-13% -$902K 1.64% 25
2021
Q2
$7.13M Buy
106,691
+709
+0.7% +$46.2K 1.77% 22
2021
Q1
$6.81M Buy
+105,982
New +$6.59M 1.71% 36

Other funds holding BMY

Greystone Financial Group's BMY Position: Q3 2026 in Review

Greystone Financial Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 84,722 shares worth $5.29M. The stake represents 1.47% of the portfolio and ranks #32 among its holdings. This is a return to the name: Greystone Financial Group previously reported a position in BMY as recently as Q1 2025.

Greystone Financial Group first reported a position in BMY in Q1 2021 and has held it in 9 quarters since. The position peaked at $9.8M in Q1 2025. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Greystone Financial Group held 84,722 shares of Bristol-Myers Squibb worth $5.29M as of Q3 2026.
  • Bristol-Myers Squibb was a new Greystone Financial Group position in Q3 2026.
  • Bristol-Myers Squibb made up 1.47% of Greystone Financial Group's portfolio in Q3 2026, its #32 holding.
  • Greystone Financial Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 9 quarters since.
  • Greystone Financial Group's Bristol-Myers Squibb position peaked at $9.8M in Q1 2025.
  • 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Greystone Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.